Page 4 - Ann Ondish News Today : Breaking News, Live Updates & Top Stories | Vimarsana

ADC Therapeutics SA: ADC Therapeutics Announces Abstracts to be Presented at the Tenth Annual Meeting of the Society of Hematologic Oncology (SOHO 2022)

ADC Therapeutics SA: ADC Therapeutics Announces Abstracts to be Presented at the Tenth Annual Meeting of the Society of Hematologic Oncology (SOHO 2022)
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesNew jerseySan francisco bayCity ofUnited kingdomLausanne biopAlex herreraRituximab loncaLoncastuximab tesirineCamidanlumab tesirine camiEugenia litzMary ann ondishCamidanlumab tesirineAmanda hamiltonJoseph camardoCompany on twitter

ADC Therapeutics SA: ADC Therapeutics and Sobi Announce ZYNLONTA (loncastuximab tesirine) Receives Positive CHMP Opinion in Europe for the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma

Approval decision expected in 4Q 2022 ADC Therapeutics SA (NYSE: ADCT) and Swedish Orphan Biovitrum AB (Sobi) today announced the Committee for Medicinal Products for Human Use (CHMP) of the European

United kingdomUnited statesNew jerseyCity ofAmanda loshbaughLausanne biopMary ann ondishAnders ullmanJohn radfordEugenia litzCompany on twitterMitsubishi tanabe pharma corporationEuropean commissionUniversity of manchesterDrug administrationFoundation trust in manchester

ADC Therapeutics to Participate in Morgan Stanley s 20th Annual Global Healthcare Conference

ADC Therapeutics SA (NYSE: ADCT) announced today that Ameet Mallik, Chief Executive Officer, will participate in a fireside chat at Morgan Stanley's 20th Annual Global Healthcare Conference on Tuesday

New jerseyUnited statesCity ofUnited kingdomLausanne biopMary ann ondishEugenia litzAmanda hamiltonMorgan stanleyCompany on twitterAmeet mallikChief executive officerAnnual global healthcare conferenceEvents presentationsSan francisco bay areaAnn ondish

ADC Therapeutics SA: ADC Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of ZYNLONTA (loncastuximab tesirine-lpyl) in Combination with Rituximab in First-Line Diffuse Large B-Cell Lymphoma

ADC Therapeutics SA: ADC Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of ZYNLONTA (loncastuximab tesirine-lpyl) in Combination with Rituximab in First-Line Diffuse Large B-Cell Lymphoma
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

New jerseyUnited statesCity ofUnited kingdomLausanne biopMary ann ondishFondazione italiana linfomiEugenia litzJoseph camardoAmanda hamiltonExchange commissionCompany on twitterDrug administrationChief medical officerCumulative illness rating scaleSan francisco bay area

ADC Therapeutics SA: ADC Therapeutics Appoints Jean-Pierre Bizzari, MD, to Board of Directors

Ameet Mallik, Chief Executive Officer of ADC Therapeutics, also joins the Board ADC Therapeutics SA (NYSE: ADCT) today announced the appointment of veteran oncology drug developer Jean-Pierre Bizzari

United statesFrance generalNew jerseyCity ofUnited kingdomLausanne biopMary ann ondishPoulenc rorerJean pierre bizzariEugenia litzAmanda hamiltonMcgill rosalindMorris goodman cancer research centreCompany on twitterFrance national cancer instituteEuropean organisation for research